http://www.femininereview.com/topics/hormone-therapy/libigel/ BioSante is competing with other BioTech firms to come out with the first offering catered to women who suffer from FSD or HSDD. Female sexual desire disorder or Hyper sexual desire disorder. Look for a potential FDA approval in 2011 if Flibanserin doesn't beat them to it. Or heck maybe both will come out!
Link to this comment:
All Comments (0)